WO2002003938A1 - Agents de couplage organiques contenant du iode pour la coloration oxydative des cheveux - Google Patents

Agents de couplage organiques contenant du iode pour la coloration oxydative des cheveux Download PDF

Info

Publication number
WO2002003938A1
WO2002003938A1 PCT/US2001/020024 US0120024W WO0203938A1 WO 2002003938 A1 WO2002003938 A1 WO 2002003938A1 US 0120024 W US0120024 W US 0120024W WO 0203938 A1 WO0203938 A1 WO 0203938A1
Authority
WO
WIPO (PCT)
Prior art keywords
aminophenol
methyl
phenylenediamine
hydroxyethyl
dihydroxyindole
Prior art date
Application number
PCT/US2001/020024
Other languages
English (en)
Inventor
Giuseppe Prota
Gottfried Wenke
Original Assignee
Clairol Incorporated
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Clairol Incorporated filed Critical Clairol Incorporated
Priority to AU2001268691A priority Critical patent/AU2001268691A1/en
Publication of WO2002003938A1 publication Critical patent/WO2002003938A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/10—Preparations for permanently dyeing the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/347—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/41—Amines
    • A61K8/415—Aminophenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings

Definitions

  • inorganic iodide compounds such as alkali metal, alkaline earth metal and ammonium iodide
  • inorganic iodide compounds can be employed as catalysts for speeding up the time for the oxidative dyeing of hair to provide mild and fast dyeing.
  • inorganic iodide compounds such as alkali metal, alkaline earth metal and ammonium iodide
  • Iodine-containing couplers of this invention also include, for example, 1-iodo-2-hydroxynaphth ⁇ l and 5-iodo-6-hydroxyquinoline of the formulae
  • the following compositions, shown in Table 1 were used for dyeing the Piedmont hair.
  • the dyeing solution comprised 0.042 mmole primary intermediate and 0.042 mmole coupler in 12 g of a typical dye base (concentration after mixing with oxidant).
  • the typical dye base comprised an alkylethersulfate, an alkanol, 25% ammonia solution, an organic acid, ethylenediaminetetraacetic acid and water.
  • the dyeing solution was mixed with 2 g of 3% hydrogen peroxide.
  • the resulting dyeing formulation was applied to the hair and permitted to remain in contact with the hair for 10 or 20 minutes as indicated in Table 1.
  • the dyed hair was then rinsed with water, shampooed and rinsed again with water and dried with a hair dryer.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Cosmetics (AREA)

Abstract

Cette invention concerne un procédé et une composition pour la coloration oxydative des cheveux. Cette composition est obtenue en faisant réagir un produit intermédiaire primaire avec un agent de couplage organique contenant du iode et est représentée par la formule (I), dans laquelle : R?1, R2, R3 et R4 ¿représentent, indépendamment les uns des autres, hydrogène, iode ou un groupe C¿1? C4 alkyle à chaîne droite ou ramifiée éventuellement substitué par un ou plusieurs substituants choisis parmi OH, NH2, NHR?8, NH8R9, OR8¿, phényle ou un noyau hétérocyclique à 5 ou 6 éléments, contenant un ou deux atomes d'azote, un atome d'oxygène ou un atome de soufre, le reste du noyau étant constitué d'atomes de carbone, ou R?2 et R3 ou R3 et R4¿ peuvent former, avec les atomes de carbone auxquels ils sont attachés, un noyau de benzène ou de pyridine éventuellement substitué par un ou plusieurs substituants choisis parmi NH¿2?, NHR?6, NR6R7¿, OH ou OR6, à condition que 1 à 3 des susbstituants de R?1, R2, R3 et R4¿ représentent iode et qu'au moins un des substituants iodo soit dans la position ortho ou para du substituant R ; R représente OH, NH¿2?, NHR?6 ou NR6R7 ¿ et, lorsque R?2 et R3 ou R3 et R4¿ forment un noyau de benzène ou de pyridine, R peut représenter hydrogène. R6 et R7 représentent, indépendamment l'un de l'autre, un groupe C¿1? C4 alkyle à chaîne droite ou ramifiée éventuellement substitué par un ou plusieurs substituants choisis parmi OH, NH2, NHR?8, NR8R9, OR8¿, phényle ou un noyau hétérocyclique à 5 ou 6 éléments contenant un ou deux atomes d'azote, un atome d'oxygène ou un atome de soufre, le reste du noyau étant constitué d'atomes de carbone. Finalement, R8 et R9 sont, indépendamment l'un de l'autre, un groupe C¿1?-C4 alkyle à chaîne droite ou ramifiée éventuellement substitué par un ou plusieurs substituants choisis parmi OH, OCH3 et NH¿2.?
PCT/US2001/020024 2000-06-29 2001-06-22 Agents de couplage organiques contenant du iode pour la coloration oxydative des cheveux WO2002003938A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2001268691A AU2001268691A1 (en) 2000-06-29 2001-06-22 Iodo-containing organic couplers for use in oxidative hair dyeing

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US60634800A 2000-06-29 2000-06-29
US09/606,348 2000-06-29

Publications (1)

Publication Number Publication Date
WO2002003938A1 true WO2002003938A1 (fr) 2002-01-17

Family

ID=24427602

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/020024 WO2002003938A1 (fr) 2000-06-29 2001-06-22 Agents de couplage organiques contenant du iode pour la coloration oxydative des cheveux

Country Status (2)

Country Link
AU (1) AU2001268691A1 (fr)
WO (1) WO2002003938A1 (fr)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006002421A3 (fr) * 2004-06-24 2006-09-21 Vertex Pharma Modulateurs de transporteurs de cassette de liaison a l'atp
US8354427B2 (en) 2004-06-24 2013-01-15 Vertex Pharmaceutical Incorporated Modulators of ATP-binding cassette transporters
US8410274B2 (en) 2005-12-28 2013-04-02 Vertex Pharmaceuticals Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
US8802700B2 (en) 2010-12-10 2014-08-12 Vertex Pharmaceuticals Incorporated Modulators of ATP-Binding Cassette transporters
US9701639B2 (en) 2014-10-07 2017-07-11 Vertex Pharmaceuticals Incorporated Co-crystals of modulators of cystic fibrosis transmembrane conductance regulator
US9751839B2 (en) 2009-03-20 2017-09-05 Vertex Pharmaceuticals Incorporated Process for making modulators of cystic fibrosis transmembrane conductance regulator
EP3216787A1 (fr) * 2004-06-24 2017-09-13 Vertex Pharmaceuticals Incorporated Modulateurs de transporteurs de cassette à liaison atp
US10272046B2 (en) 2012-02-27 2019-04-30 Vertex Pharmaceuticals Incorporated Pharmaceutical composition and administrations thereof
US10646481B2 (en) 2008-08-13 2020-05-12 Vertex Pharmaceuticals Incorporated Pharmaceutical composition and administrations thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6090160A (en) * 1989-11-10 2000-07-18 L'oreal Method for dyeing keratin fibers with compositions which contain 6- or 7-hydroxyindole derivatives as couplers and oxidation dye precursors
US6090162A (en) * 1997-11-07 2000-07-18 L'oreal S.A. Composition for the oxidation dyeing of keratinous fibres comprising a 5-substituted 3,4-diaminopyrazole and a halogenated meta-aminophenol

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6090160A (en) * 1989-11-10 2000-07-18 L'oreal Method for dyeing keratin fibers with compositions which contain 6- or 7-hydroxyindole derivatives as couplers and oxidation dye precursors
US6090162A (en) * 1997-11-07 2000-07-18 L'oreal S.A. Composition for the oxidation dyeing of keratinous fibres comprising a 5-substituted 3,4-diaminopyrazole and a halogenated meta-aminophenol

Cited By (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9090619B2 (en) 2004-06-24 2015-07-28 Vertex Pharmaceuticals Incorporated Modulators of ATP-binding cassette transporters
US8101767B2 (en) 2004-06-24 2012-01-24 Vertex Pharmaceuticals Incorporated Modulators of ATP-binding cassette transporters
US8324242B2 (en) 2004-06-24 2012-12-04 Vertex Pharmaceutical Incorporated Modulators of ATP-binding cassette transporters
US8354427B2 (en) 2004-06-24 2013-01-15 Vertex Pharmaceutical Incorporated Modulators of ATP-binding cassette transporters
US10662192B2 (en) 2004-06-24 2020-05-26 Vertex Pharmaceuticals Incorporated Modulators of ATP-binding cassette transporters
US8614327B2 (en) 2004-06-24 2013-12-24 Vertex Pharmaceuticals Incorporated Modulators of ATP-binding cassette transporters
US8629162B2 (en) 2004-06-24 2014-01-14 Vertex Pharmaceuticals Incorporated Modulators of ATP-binding cassette transporters
US8741925B2 (en) 2004-06-24 2014-06-03 Vertex Pharmaceuticals Incorporated Modulators of ATP-binding cassette transporters
EP3216787A1 (fr) * 2004-06-24 2017-09-13 Vertex Pharmaceuticals Incorporated Modulateurs de transporteurs de cassette à liaison atp
WO2006002421A3 (fr) * 2004-06-24 2006-09-21 Vertex Pharma Modulateurs de transporteurs de cassette de liaison a l'atp
US9670163B2 (en) 2005-12-28 2017-06-06 Vertex Pharmaceuticals Incorporated Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
US11291662B2 (en) 2005-12-28 2022-04-05 Vertex Pharmaceuticals Incorporated Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
US9139530B2 (en) 2005-12-28 2015-09-22 Vertex Pharmaceuticals Incorporated Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
US8754224B2 (en) 2005-12-28 2014-06-17 Vertex Pharmaceuticals Incorporated Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
US9931334B2 (en) 2005-12-28 2018-04-03 Vertex Pharmaceuticals Incorporated Solid forms of N[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
US8410274B2 (en) 2005-12-28 2013-04-02 Vertex Pharmaceuticals Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
US10537565B2 (en) 2005-12-28 2020-01-21 Vertex Pharmaceuticals Incorporated Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
US10646481B2 (en) 2008-08-13 2020-05-12 Vertex Pharmaceuticals Incorporated Pharmaceutical composition and administrations thereof
US11564916B2 (en) 2008-08-13 2023-01-31 Vertex Pharmaceuticals Incorporated Pharmaceutical composition and administrations thereof
US9751839B2 (en) 2009-03-20 2017-09-05 Vertex Pharmaceuticals Incorporated Process for making modulators of cystic fibrosis transmembrane conductance regulator
US8802700B2 (en) 2010-12-10 2014-08-12 Vertex Pharmaceuticals Incorporated Modulators of ATP-Binding Cassette transporters
US10272046B2 (en) 2012-02-27 2019-04-30 Vertex Pharmaceuticals Incorporated Pharmaceutical composition and administrations thereof
US11147770B2 (en) 2012-02-27 2021-10-19 Vertex Pharmaceuticals Incorporated Pharmaceutical composition and administrations thereof
US11752106B2 (en) 2012-02-27 2023-09-12 Vertex Pharmaceuticals Incorporated Pharmaceutical composition and administrations thereof
US9701639B2 (en) 2014-10-07 2017-07-11 Vertex Pharmaceuticals Incorporated Co-crystals of modulators of cystic fibrosis transmembrane conductance regulator

Also Published As

Publication number Publication date
AU2001268691A1 (en) 2002-01-21

Similar Documents

Publication Publication Date Title
US6503282B1 (en) Means and method for dying keratinic fibers
HU224430B1 (hu) Keratintartalmú rostok oxidációs festésére való készítmény és festési eljárás a készítmény alkalmazásával
EP1120105B1 (fr) Procédé de préparation du (Diamino-2,5 phényl)éthanol-1 et utilisation de ce composé en coloration capillaire
PL180301B1 (pl) Kompozycja do utleniajacego farbowania wlókien keratynowych PL PL PL PL PL PL PL
BRPI0614627A2 (pt) agentes oxidantes para tingimento de cabelos contendo derivados de m-aminofenol
JP2003518481A (ja) ケラチン含有繊維を染色するためのメチルキノリニウム化合物の使用
WO2002003938A1 (fr) Agents de couplage organiques contenant du iode pour la coloration oxydative des cheveux
CA2253981C (fr) Nouveaux benzenes bis-(2,4-diaminophenoxy) et leur utilisation en tant qu'elements de couplage dans des colorants capillaires oxidatifs et methodes
EP1006104B1 (fr) Remplacement de p-aminophenol et son utilisation en teinturerie
EP1129688B1 (fr) Composition de teinture pour cheveux utilisant un sel mineral de peroxymonosulfate comme agent oxydant
US10444157B2 (en) Method of assessing hair colour changes
BRPI0005896B1 (pt) derivados de 1,4 - diaminobenzeno e agentes de tingimento contendo esses compostos
US6200353B1 (en) Coupler for use in oxidative hair dyeing
AU2002214975B2 (en) Novel 1,4-Diamino-2-alkenyl-benzene derivatives and colorants containing said compounds
AU2001291054B2 (en) Yellow hair color dyeing composition having improved wear properties
US5865856A (en) 2, 5-diaminobenzonitrile compounds and oxidation hair dye compositions containing same
AU2001291054A1 (en) Yellow hair color dyeing composition having improved wear properties
JP2002508351A (ja) 新規ｐ−アミノフェノール誘導体およびその使用
DE19859809A1 (de) Mittel zum Färben von keratinhaltigen Fasern
EP1292268A2 (fr) Agent de coloration de fibres keratiniques
ES2249420T3 (es) Derivados n-bencil-p-fenilendiamina que contienen agentes colorantes para fibras de queratina y nuevos derivados n-bencil-p-fenilendiamina.
US20030115683A1 (en) Novel 1,4-diamino-2-(thiazol-2-yl)benzene derivatives and dyes containing said compounds
DE19916032A1 (de) Verfahren zum Färben keratinischer Fasern und Färbemittel
AU2003282008A1 (en) Hair treatment agent
CZ374099A3 (cs) Použití nenasycených aldehydů

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP